Fla. Stat. 383.147
Sickle cell disease and sickle cell trait registry


(1)

If a newborn as defined in s. 383.145(2) is identified as having sickle cell disease or sickle cell trait through the newborn screening program as described in s. 383.14, the department must:Notify the parent or guardian of the newborn and provide information regarding the availability and benefits of genetic counseling.Submit the results of such screening for inclusion in the sickle cell registry established under paragraph (2)(a), unless the parent or guardian of the newborn provides an opt-out form obtained from the department, or otherwise indicates in writing to the department his or her objection to having the newborn included in the sickle cell registry.

(a)

Notify the parent or guardian of the newborn and provide information regarding the availability and benefits of genetic counseling.

(b)

Submit the results of such screening for inclusion in the sickle cell registry established under paragraph (2)(a), unless the parent or guardian of the newborn provides an opt-out form obtained from the department, or otherwise indicates in writing to the department his or her objection to having the newborn included in the sickle cell registry.

(2)(a)

The Department of Health shall contract with a community-based sickle cell disease medical treatment and research center to establish and maintain a registry for individuals who are identified as having sickle cell disease or carrying a sickle cell trait. The sickle cell registry must track sickle cell disease outcome measures, except as provided in paragraph (1)(b).In addition to newborns identified and included in the registry under subsection (1), other persons living in this state who have been identified as having sickle cell disease or carrying a sickle cell trait may choose to be included in the registry by providing the department with notification as prescribed by rule.The Department of Health shall also establish a system to ensure that the community-based sickle cell disease medical treatment and research center notifies the parent or guardian of a child who has been included in the registry that a follow-up consultation with a physician is recommended. Such notice must be provided to the parent or guardian of such child at least once during early adolescence and once during late adolescence. The department shall make every reasonable effort to notify persons included in the registry who are 18 years of age that they may request to be removed from the registry by submitting a form prescribed by the department by rule. The department shall also provide to such persons information regarding available educational services, genetic counseling, and other beneficial resources.

(2)(a)

The Department of Health shall contract with a community-based sickle cell disease medical treatment and research center to establish and maintain a registry for individuals who are identified as having sickle cell disease or carrying a sickle cell trait. The sickle cell registry must track sickle cell disease outcome measures, except as provided in paragraph (1)(b).

(b)

In addition to newborns identified and included in the registry under subsection (1), other persons living in this state who have been identified as having sickle cell disease or carrying a sickle cell trait may choose to be included in the registry by providing the department with notification as prescribed by rule.

(c)

The Department of Health shall also establish a system to ensure that the community-based sickle cell disease medical treatment and research center notifies the parent or guardian of a child who has been included in the registry that a follow-up consultation with a physician is recommended. Such notice must be provided to the parent or guardian of such child at least once during early adolescence and once during late adolescence. The department shall make every reasonable effort to notify persons included in the registry who are 18 years of age that they may request to be removed from the registry by submitting a form prescribed by the department by rule. The department shall also provide to such persons information regarding available educational services, genetic counseling, and other beneficial resources.

(3)

The Department of Health shall adopt rules to implement this section.

Source: Section 383.147 — Sickle cell disease and sickle cell trait registry, https://www.­flsenate.­gov/Laws/Statutes/2024/0383.­147 (accessed Aug. 7, 2025).

383.04
Prophylactic required for eyes of infants
383.06
Report of inflammation or discharge in infant’s eyes
383.07
Penalty for violation
383.11
Reports
383.011
Administration of maternal and child health programs
383.13
Use of information by department
383.013
Prenatal care
383.014
Perinatal mental health care
383.14
Screening for metabolic disorders, other hereditary and congenital disorders, and environmental risk factors
383.015
Breastfeeding
383.15
Legislative intent
383.016
Breastfeeding policy for “baby-friendly” facilities providing maternity services and newborn infant care
383.16
Definitions
383.17
Regional perinatal intensive care centers program
383.18
Contracts
383.19
Standards
383.30
Birth Center Licensure Act
383.31
Selection of clients
383.32
Clinical records
383.33
Administrative penalties
383.50
Treatment of surrendered infant
383.51
Confidentiality
383.0131
Pregnancy and parenting resources website
383.141
Prenatally diagnosed conditions
383.145
Newborn, infant, and toddler hearing screening
383.146
Infants and toddlers who are deaf or hard of hearing
383.147
Sickle cell disease and sickle cell trait registry
383.148
Environmental risk screening
383.216
Community-based prenatal and infant health care
383.301
Licensure and regulation of birth centers
383.302
Definitions of terms used in ss
383.305
Licensure
383.307
Administration of birth center
383.308
Birth center facility and equipment
383.309
Minimum standards for birth centers and advanced birth centers
383.311
Education and orientation for birth center clients and their families
383.312
Prenatal care of birth center clients
383.313
Birth center performance of laboratory and surgical services
383.315
Agreements with consultants for advice or services
383.316
Transfer and transport of clients to hospitals
383.318
Postpartum care for birth center clients and infants
383.324
Inspections and investigations
383.325
Inspection reports
383.327
Birth and death records
383.332
Establishing, managing, or operating a birth center without a license
383.402
Child abuse death review
383.412
Public records and public meetings exemptions
383.2161
Maternal and child health report
383.2162
Black infant health practice initiative
383.2163
Telehealth Minority Maternity Care Program
383.3081
Advanced birth center designation
383.3105
Patients consenting to adoptions
383.3131
Advanced birth center performance of laboratory and surgical services
383.3361
Limitations on civil and administrative liability
383.3362
Sudden Unexpected Infant Death
383.21625
Fetal and infant mortality review committees
383.33625
Stephanie Saboor Grieving Parents Act

Current through Fall 2025

§ 383.147. Sickle cell disease & sickle cell trait registry's source at flsenate​.gov